Understanding acceptance of and adherence to a new formulation of paediatric antiretroviral treatment in the form of pellets (LPV/r)-A realist evaluation.
Ariadna Nebot GiraltChristiana NöstlingerJanice LeeOlawale SalamiMarc LallemantWashington Onyango-OumaIsaac NyamongoBruno MarchalPublished in: PloS one (2019)
Formulating combined antiretroviral treatment in the form of pellets is clearly a more acceptable solution for infants and children and their caregivers compared to the syrup. Further research in non-trial settings may shed light on factors related to providers, services and the health system that contribute to better adherence of such formulations.
Keyphrases
- hiv infected
- human immunodeficiency virus
- healthcare
- hiv aids
- emergency department
- primary care
- clinical trial
- young adults
- hiv positive
- intensive care unit
- palliative care
- mental health
- combination therapy
- drug delivery
- type diabetes
- study protocol
- metabolic syndrome
- adipose tissue
- insulin resistance
- replacement therapy
- smoking cessation
- solid state